Hpv-associated Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Hpv-associated Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) [Phase 2]
A Phase 2 trial assesses neoadjuvant chemotherapy combined with a PD-1 inhibitor for head and neck squamous cell carcinoma with the goal of …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Shortened Course Adjuvant Radiotherapy Following TORS [Phase 2]
Phase 2 clinical trial evaluating a shortened course of adjuvant radiotherapy following transoral robotic surgery for HPV-associated orophar…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study [Phase 2]
This is a Phase 2 clinical trial (ReACT) evaluating risk-adapted therapy guided by circulating tumor HPV DNA in HPV-associated and HPV-posit…